Nasopharyngeal Cancer

Our head and neck specialists offer evidence-based, compassionate care for people with nasopharyngeal cancer, which affects the nasopharynx, located at the top part of the throat. Through our clinical trials, we offer access to new imaging techniques that help your doctors diagnose nasopharyngeal cancer and guide treatment decisions. Then, our team of radiation oncologists, medical oncologists, and other experts develops a personalized care plan that’s right for you.

Clinical Trials and Research Studies

Phase 1/2

A Phase 1/2 Study Exploring the Safety Tolerability and Efficacy of INCAGN01949 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Learn More

Phase 1

A PHASE I AND EXPANSION COHORT STUDY OF ADJUVANT CISPLATIN INTENSITY-MODULATED RADIOTHERAPY AND MK-3475 (PEMBROLIZUMAB) IN HIGH-RISK HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)

Learn More

Phase 1

A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Learn More

Phase 1

A Phase 1 Open-Label Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety Tolerability Activity and Pharmacokinetics of REGN3767 (anti-LAG-3 mAb) Administered Alone or in Combination with REGN2810 (anti-PD-1 mAb) in Patients with Ad

Learn More